Incentive and Non-Statutory Stock Option Plan (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
Mar. 31, 2019 |
Mar. 31, 2018 |
Jun. 30, 2018 |
|
Number of stock options | 40,386 | 40,386 | 53,462 | ||
Option term | 7 months 10 days | ||||
Compensation expense | $ 110,939 | $ 448,221 | $ 980,682 | $ 1,281,763 | |
Compensation expense related to unvested options yet to be recognized | $ 593,480 | $ 593,480 | |||
Stock Options [Member] | |||||
Number of stock options | 40,386 | 40,386 | |||
Exercise price of option | $ 6.50 | $ 6.50 | |||
Option term | 1 year | ||||
Compensation expense | $ 43,612 |
X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|